目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Liver Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Incidence of Liver Cancer
3.2.1.2. Technological Advancements
3.2.1.3. Extensive R&D For Developing Novel Testing Solutions
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Diagnostic imaging
3.3. Liver Cancer Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Liver Cancer Diagnostics Market: Test type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Liver Cancer Diagnostics Market: Product Movement Analysis
4.3. Liver Cancer Diagnostics Market Size & Trend Analysis, by test type, 2018 to 2030 (USD Million)
4.3.1. Global Laboratory Tests Market, 2018 - 2030 (USD Million)
4.3.1.1. Biomarkers
4.3.1.1.1. Global biomarkers market, 2018 - 2030 (USD Million)
4.3.1.1.1.1. Oncofetal and Glycoprotein Antigens
4.3.1.1.1.1.1. Global oncofetal and glycoprotein antigens market, 2018 - 2030 (USD Million)
4.3.1.1.1.2. Enzymes and Isoenzymes
4.3.1.1.1.2.1. Global enzymes and isoenzymes market, 2018 - 2030 (USD Million)
4.3.1.1.1.3. Growth Factors and Receptors
4.3.1.1.1.3.1. Global growth factors and receptors market, 2018 - 2030 (USD Million)
4.3.1.1.1.4. Molecular Markers
4.3.1.1.1.4.1. Global molecular markers market, 2018 - 2030 (USD Million)
4.3.1.1.1.5. Pathological Biomarkers
4.3.1.1.1.5.1. Global pathological biomarkers market, 2018 - 2030 (USD Million)
4.3.1.2. Blood Tests
4.3.1.2.1. Global blood tests market, 2018 - 2030 (USD Million)
4.3.2. Imaging
4.3.2.1. Global Imaging Market, 2018 - 2030 (USD Million)
4.3.3. Endoscopy
4.3.3.1. Global Endoscopy Market, 2018 - 2030 (USD Million)
4.3.4. Biopsy
4.3.4.1. Global Biopsy Market, 2018 - 2030 (USD Million)

Chapter 5. Liver Cancer Diagnostics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Liver Cancer Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospitals & Diagnostic Laboratories
5.5.1. Global Hospitals & Diagnostic Laboratories market, 2018 - 2030 (USD Million)
5.6. Academic & Research Institutes
5.6.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
5.7. Pharmaceutical & CRO Laboratories
5.7.1. Global Pharmaceutical & CRO Laboratories market, 2018 - 2030 (USD Million)

Chapter 6. Liver Cancer Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. North America: SWOT Analysis
6.5.2. U.S.
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/Reimbursement
6.5.2.3. Competitive scenario
6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/Reimbursement
6.5.3.3. Competitive scenario
6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/Reimbursement
6.5.4.3. Competitive scenario
6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. Europe: SWOT Analysis
6.6.2. UK
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/Reimbursement
6.6.2.3. Competitive scenario
6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/Reimbursement
6.6.3.3. Competitive scenario
6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. France
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/Reimbursement
6.6.4.3. Competitive scenario
6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/Reimbursement
6.6.5.3. Competitive scenario
6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/Reimbursement
6.6.6.3. Competitive scenario
6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Norway
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/Reimbursement
6.6.7.3. Competitive scenario
6.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/Reimbursement
6.6.8.3. Competitive scenario
6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.9. Denmark
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework/Reimbursement
6.6.9.3. Competitive scenario
6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Asia Pacific: SWOT Analysis
6.7.2. Japan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/Reimbursement
6.7.2.3. Competitive scenario
6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. China
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/Reimbursement
6.7.3.3. Competitive scenario
6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. India
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/Reimbursement
6.7.4.3. Competitive scenario
6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. Australia
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/Reimbursement
6.7.5.3. Competitive scenario
6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. South Korea
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/Reimbursement
6.7.6.3. Competitive scenario
6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.7. Thailand
6.7.7.1. Key country dynamics
6.7.7.2. Regulatory framework/Reimbursement
6.7.7.3. Competitive scenario
6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Latin America: SWOT Analysis
6.8.2. Brazil
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/Reimbursement
6.8.2.3. Competitive scenario
6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/Reimbursement
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. MEA: SWOT Analysis
6.9.2. South Africa
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/Reimbursement
6.9.2.3. Competitive scenario
6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/Reimbursement
6.9.3.3. Competitive scenario
6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. UAE
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/Reimbursement
6.9.4.3. Competitive scenario
6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key country dynamics
6.9.5.2. Regulatory framework
6.9.5.3. Competitive scenario
6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2024
7.3.4. Abbott Laboratories
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Services benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Thermo Fisher Scientific, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Services benchmarking
7.3.5.4. Strategic initiatives
7.3.6. F. Hoffmann-La Roche Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Services benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Qiagen N.V.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Services benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens Healthineers
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Services benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Becton, Dickinson & Company
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Services benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Illumina, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Services benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Epigenomics AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Services benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Koninklijke Philips N.V.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Services benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Fujifilm Medical Systems U.S.A., Inc.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Services benchmarking
7.3.13.4. Strategic initiatives

List of Tables
Table 1 List of abbreviations
Table 2 North America Liver cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 4 North America Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 5 U.S Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 6 U.S Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 7 Canada Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 8 Canada Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 9 Mexico Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 10 Mexico Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 11 Europe Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 12 Europe Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 13 UK Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 14 UK Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 15 Germany Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 16 Germany Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 17 France Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 18 France Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 19 Italy Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 20 Italy Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 21 Spain Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 22 Spain Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 23 Denmark Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 24 Denmark Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 25 Sweden Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 26 Sweden Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 27 Norway Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 28 Norway Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 31 Japan Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 32 Japan Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 33 China Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 34 China Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 35 India Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 36 India Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 37 Australia Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 38 Australia Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 39 South Korea Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 40 South Korea Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 41 Thailand Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 42 Thailand Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 43 Latin America Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 44 Latin America Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 45 Brazil Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 46 Brazil Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 47 Argentina Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 48 Argentina Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 49 MEA Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 50 MEA Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 51 South Africa Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 52 South Africa Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 55 UAE Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 56 UAE Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)
Table 57 Kuwait Liver cancer diagnostics market, by test type, 2018 - 2030 (USD Million)
Table 58 Kuwait Liver cancer diagnostics market, by end user, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Liver cancer diagnostics market: market outlook
Fig. 14 Liver cancer diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Liver cancer diagnostics market driver impact
Fig. 20 Liver cancer diagnostics market restraint impact
Fig. 21 Liver cancer diagnostics market strategic initiatives analysis
Fig. 22 Liver cancer diagnostics market: Test type movement analysis
Fig. 23 Liver cancer diagnostics market: Test type outlook and key takeaways
Fig. 24 Laboratory Tests Liver Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 25 Imaging Liver Cancer Diagnostics estimates and forecast, 2018 - 2030
Fig. 26 Endoscopy Liver Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 27 Biopsy Liver Cancer Diagnostics market estimates and forecast, 2018 - 2030
Fig. 28 Liver cancer diagnostics market: End-use movement analysis
Fig. 29 Liver cancer diagnostics market: End-use outlook and key takeaways
Fig. 30 Hospitals & Diagnostic Laboratories market estimates and forecasts, 2018 - 2030
Fig. 31 Academic and Research Institutes market estimates and forecasts, 2018 - 2030
Fig. 32 Pharmaceutical & CRO Laboratories market estimates and forecasts, 2018 - 2030
Fig. 33 Global Liver cancer diagnostics market: Regional movement analysis
Fig. 34 Global Liver cancer diagnostics market: Regional outlook and key takeaways
Fig. 35 Global Liver cancer diagnostics market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America: SWOT
Fig. 42 Europe SWOT
Fig. 43 Asia Pacific SWOT
Fig. 44 Latin America SWOT
Fig. 45 MEA SWOT
Fig. 46 North America, by country
Fig. 47 North America
Fig. 48 North America market estimates and forecasts, 2018 - 2030
Fig. 49 U.S.
Fig. 50 U.S. market estimates and forecasts, 2018 - 2030
Fig. 51 Canada
Fig. 52 Canada market estimates and forecasts, 2018 - 2030
Fig. 53 Mexico
Fig. 54 Mexico market estimates and forecasts, 2018 - 2030
Fig. 55 Europe
Fig. 56 Europe market estimates and forecasts, 2018 - 2030
Fig. 57 UK
Fig. 58 UK market estimates and forecasts, 2018 - 2030
Fig. 59 Germany
Fig. 60 Germany market estimates and forecasts, 2018 - 2030
Fig. 61 France
Fig. 62 France market estimates and forecasts, 2018 - 2030
Fig. 63 Italy
Fig. 64 Italy market estimates and forecasts, 2018 - 2030
Fig. 65 Spain
Fig. 66 Spain market estimates and forecasts, 2018 - 2030
Fig. 67 Denmark
Fig. 68 Denmark market estimates and forecasts, 2018 - 2030
Fig. 69 Sweden
Fig. 70 Sweden market estimates and forecasts, 2018 - 2030
Fig. 71 Norway
Fig. 72 Norway market estimates and forecasts, 2018 - 2030
Fig. 73 Asia Pacific
Fig. 74 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 75 China
Fig. 76 China market estimates and forecasts, 2018 - 2030
Fig. 77 Japan
Fig. 78 Japan market estimates and forecasts, 2018 - 2030
Fig. 79 India
Fig. 80 India market estimates and forecasts, 2018 - 2030
Fig. 81 Thailand
Fig. 82 Thailand market estimates and forecasts, 2018 - 2030
Fig. 83 South Korea
Fig. 84 South Korea market estimates and forecasts, 2018 - 2030
Fig. 85 Australia
Fig. 86 Australia market estimates and forecasts, 2018 - 2030
Fig. 87 Latin America
Fig. 88 Latin America market estimates and forecasts, 2018 - 2030
Fig. 89 Brazil
Fig. 90 Brazil market estimates and forecasts, 2018 - 2030
Fig. 91 Argentina
Fig. 92 Argentina market estimates and forecasts, 2018 - 2030
Fig. 93 Middle East and Africa
Fig. 94 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 95 South Africa
Fig. 96 South Africa market estimates and forecasts, 2018 - 2030
Fig. 97 Saudi Arabia
Fig. 98 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 99 UAE
Fig. 100 UAE market estimates and forecasts, 2018 - 2030
Fig. 101 Kuwait
Fig. 102 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 103 Market share of key market players- Liver cancer diagnostics market